Jason E Cain

14PUBLICATIONS
182CO-AUTHORS
Haematological tumoursMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 16, 2026
H3K27M Mutation Modulates the Antigenic Landscape in Diffuse Midline Glioma.

|Oct 16, 2023
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype.

Vijesh G Vaghjiani, Catherine R Cochrane, W Samantha N Jayasekara

|Aug 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji

|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|Mar 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.

Zacary P Germon, Jonathan R Sillar, Abdul Mannan

|May 06, 2022
Distinctive molecular features of regenerative stem cells in the damaged male germline.

Hue M La, Jinyue Liao, Julien M D Legrand

Pageof 3

Frequent Collaborators

5 joint publications

Matthew D Dun

5 joint publications

Ryan J Duchatel

4 joint publications

Izac J Findlay

4 joint publications

Javad Nazarian